Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Il corso del sonno: un intervento online sul sonno per adulti con difficoltà di sonno auto-riferite

2 novembre 2026 aggiornato da: University of Regina

Il corso sul sonno: esame della fattibilità, dell'accettabilità e dell'efficacia di un intervento online sul sonno per adulti con difficoltà di sonno auto-riferite

This study evaluates an internet-delivered cognitive behavioural therapy for insomnia (ICBTi) intervention, known as the Sleep Course, within a routine online therapy clinic (the Online Therapy Unit). The Sleep Course will specifically be offered to clients with self-reported sleep difficulties (i.e., falling or staying asleep or waking early) and daytime distress and or impairment. This study aims to replicate the effectiveness and acceptability of the previously evaluated Sleep Course when delivered in Australia. The investigators will also assess uptake and completion rates within the clinic as well as demographic and clinical characteristics of individuals enrolled in the Sleep Course.

Panoramica dello studio

Stato

Reclutamento

Intervento / Trattamento

Descrizione dettagliata

To improve access to effective psychological treatment, Internet-delivered Cognitive Behaviour Therapy (ICBT) has been developed. ICBT delivers therapeutic content via structured online lessons usually over several months, teaching the same skills that are taught in face-to-face cognitive behaviour therapy. In routine practice, ICBT is often accompanied by brief therapist support offered via secure messaging and/or phone calls. A growing body of research supports the effectiveness of ICBT for a variety of conditions, including depression, anxiety, alcohol misuse, and insomnia. For insomnia, ICBTi has been shown to result in improvements on various sleep measures, comorbid anxiety and depression, and quality of life, with outcomes comparable to face-to-face treatment.

Importantly, there are a growing number of studies showing the effectiveness of ICBT for depression and anxiety extends to routine care. However, there are fewer studies exploring ICBTi in routine care, particularly when minimal exclusion criteria are imposed. This research is important because sleep difficulties and insomnia are common, distressing and often disabling and frequently comorbid with mood or anxiety disorders as well as various physical conditions. Moreover, access to specialized psychological services, such as CBTi, is often limited, despite CBTi being a well-established first-line treatment, which many clients find more acceptable than medication. Two key aspects of CBTi are stimulus control and sleep restriction though other strategies such as cognitive restructuring and relaxation are also commonly included. ICBTi offers a promising approach for expanding access to evidence-based treatment for insomnia. This is especially critical given the high personal and societal costs of leaving insomnia untreated.

From past research, the investigators have found that approximately 73% of clients enrolled in the routine clinic that offers ICBT for anxiety and depression also reported significant sleep problems. Of these, only 30% accessed an additional sleep resource to address their sleep concerns. While improvements in sleep were observed among all clients enrolled in ICBT, average post-test treatment scores indicated many clients still had significant difficulties with insomnia. In another study conducted within the investigators' Unit, the investigators explored whether offering an insomnia-focussed lesson at the beginning of ICBT would improve insomnia symptoms. In this study, the investigators found that clients experienced large reductions in insomnia symptoms at a faster rate than when clients did not receive the insomnia lesson at the beginning of ICBT. However, even with these improvements, many clients continued to report clinically significant levels of insomnia post-treatment, indicating that further support for insomnia symptoms may be beneficial.

Overall, given that the investigators ICBT program does not appear to be fully meeting the sleep needs of clients who have depression and anxiety, as well as the needs of clients who have sleep problems or insomnia and do not want ICBT for depression and anxiety, the investigators believe it would be valuable to explore the benefits of offering ICBTi in the routine care clinic. This is especially important for routine care settings where inclusivity is key and services should be broadly accessible.

One such program that shows promise among clients with diverse sleep difficulties is the Sleep Course. The current study therefore aims to explore the extent to which this ICBTi program will be used by clients seeking services within the routine online clinic. Additionally, the study will explore the demographic and clinical characteristics of clients who seek ICBTi, as well as the acceptability and effectiveness of the ICBTi program. The data collected will shape long-term practices within the Online Therapy Unit and has potential to significantly enhance service delivery. The research will also provide valuable insights for other online clinics regarding the potential of offering ICBTi in routine online care. By exploring the program's use, client characteristics, acceptability, and effectiveness, this study will contribute to a broader understanding of how ICBTi can be successfully integrated into routine online services, ultimately improving access to evidence-based treatment for insomnia.

Tipo di studio

Interventistico

Iscrizione (Stimato)

56

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Saskatchewan
      • Regina, Saskatchewan, Canada, S4S 0A2
        • Reclutamento
        • Online Therapy Unit
        • Contatto:
        • Investigatore principale:
          • Heather D Hadjistavropoulos, PhD
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • 18 years or older;
  • Living in Saskatchewan for the treatment period;
  • Self-reported difficulty with sleep (i.e., difficulty falling, staying asleep or waking up early) causing daytime distress and or impairment;
  • Has comfort using and access to a device or computer with Internet in a private location;
  • Read and understand English;
  • Consent to Sleep Course, online therapy as provided by Unit, and associated research.

Exclusion Criteria:

  • Current severe medical or psychiatric disorder that requires immediate or alternate treatment (e.g. current and recent mania or psychosis requiring hospitalization, actively suicidal and unable to keep themselves safe, medical condition requiring immediate surgery or other invasive treatment, severe substance use);
  • Taking part in another treatment at our clinic.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: ICBT for insomnia

Therapist-guided, Internet-delivered cognitive behavioral therapy for insomnia (ICBTi)

The Sleep Course previously developed and evaluated in Australia will be delivered to clients meeting participation criteria. The Sleep Course is four lessons long and is offered with once weekly therapist support for 8 weeks where clients are encouraged to email the assigned therapist for support each week. The therapist reviews client progress in the Course and emails clients once per week on a designated check in date. Sometimes the therapist will call the client. Phone calls are typically made if a client is not logging in or if the therapist feels that a phone call would be a helpful way to provide support.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in insomnia symptoms
Lasso di tempo: Screening, weeks 1, 2, 3, 4, 5, 6, 7 (post-treatment), and 3-month follow-up

Insomnia Severity Index (ISI). Includes 7 items rated on a 0 to 4 scale. Higher total scores indicate greater severity of insomnia symptoms over the past two weeks. Scores range from 0 to 28.

Screening, weeks 1, 2, 3, 4, 5, 6, 7 (post-treatment), and 3-month follow-up

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in sleep diary scores
Lasso di tempo: Baseline and week 7 (post treatment)

The core Consensus Sleep Diary (CSD) consisting of 9 items, will be administered to clients each morning for 7 consecutive days, asking about their sleep the previous night. Participants will record the time they went to bed, time to initiate sleep, time they woke up in the morning, time of final awakening, and time they got out of bed in the morning (in clock). Participants will also record the number (in numbers) and duration of awakenings during the night (in minutes). Using a 6-point Likert scale ranging from 0 to 5, participants will indicate the quality of their sleep with higher scores indicating more restorative sleep quality. An additional open-ended item is added for comments. Two extra questions on napping-extracted from the Expanded Consensus Sleep Diary for Morning- will be included. Using this, participants will record if they napped the previous day (yes/no), and for how long (in minutes). There is no overall score for the scale, each parameter is analyzed separately.

Baseline and week 7 (post treatment)
Change in sleep quality
Lasso di tempo: Screening, week 7 (post treatment) and 3-month follow-up

Pittsburgh Sleep Quality Index (PSQI). A 19-item survey rated on a 0 to 3-point scale. This survey is used to assess sleep dysfunction over the past month and produces scores for subjective sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbance, use of medication, daytime dysfunction, and higher scores indicate severe difficulties in each area. A sum of the scores from these factors produces a global score between 0-21, where higher global scores indicate more severe sleep disturbances.

Screening, week 7 (post treatment) and 3-month follow-up
Change in sleep quality
Lasso di tempo: Weeks 1, 2, 3, 4, 5, and 6

Pittsburgh Sleep Quality Index (PSQI- 4 Items). A 4-item survey that assesses quality of sleep. Items on this scale are measured on a 4-point Likert scale ranging from 0-3, and scores range from 0-12, with higher scores indicating worse sleep quality. This measure is used by clinicians to monitor client sleep.

Weeks 1, 2, 3, 4, 5, and 6
Change in attitudes and beliefs about sleep
Lasso di tempo: Screening, week 7 (post-treatment) and 3-month follow-up

Dysfunctional Beliefs and Attitudes about Sleep- 16 item (DBAS-16) with items rated on a 0 to 10-point scale. Scores range from 0 to 160 with higher scores indicating greater dysfunctional beliefs about sleep.

Screening, week 7 (post-treatment) and 3-month follow-up
Change in depression
Lasso di tempo: Screening, week7 (post treatment) and 3-month follow-up

Patient Health Questionnaire - 9 Item (PHQ-9). Includes 9 items rated 0 to 3. Higher total scores indicate greater severity of depression. Scores range from 0 to 27. Clinical cutoff of ≥10 indicate clinically significant depression.

Screening, week7 (post treatment) and 3-month follow-up
Change in depression and anxiety
Lasso di tempo: Weeks 1, 2, 3, 4, 5, and 6

Patient Health Questionnaire - 4 Item (PHQ-4) involves rating 4 items on a scale from 0 to 3, with scores ranging from 0 to 12. Higher total scores indicate greater severity of depression and anxiety symptoms. Additionally, item #9 of the PHQ-9 is presented alongside the PHQ-4 to monitor client's wellbeing. This item is rated on a scale from 0 to 3, with higher scores indicating more severe self-harm or suicidal ideology. However, the score from this item is not included in the overall PHQ-4 score. This measure is used by clinicians to monitor client's mental health symptoms.

Weeks 1, 2, 3, 4, 5, and 6
Change in anxiety
Lasso di tempo: Screening, week 7 (post treatment) and 3-month follow-up

Generalized Anxiety Disorder - 7 Item (GAD-7). Includes 7-items used to assess generalized anxiety disorder. Items are rated on a 0 to 3-point Likert scale. Total score range from 0 to 21, and higher total scores indicate greater severity of anxiety. Clinical cutoff of ≥10 indicates clinically significant anxiety.

Screening, week 7 (post treatment) and 3-month follow-up
Lesson reflection
Lasso di tempo: Weeks 2, 3, 4, 5, 6, and 7 (post treatment)

Lesson reflection questionnaire - A bespoke 6-item survey that inquires about which lesson and resources clients worked on, effort, understanding, helpfulness, and client successes and challenges over the previous week. This survey is used for clinicians to monitor treatment. No score is calculated or created.

Weeks 2, 3, 4, 5, 6, and 7 (post treatment)
Evaluation of treatment
Lasso di tempo: Week 7 (post treatment)

Treatment Satisfaction Survey. A bespoke questionnaire consisting of 15 items with varying response formats measuring treatment satisfaction. The questionnaire utilizes a combination of Likert-scale (5-point (0-4)and 6-point (0-5) ), open-ended, and dichotomous yes/no response options to gauge participants' perception of the course. No overall score is calculated or reported for this questionnaire.

Week 7 (post treatment)
Engagement
Lasso di tempo: Collects engagement from time of consent to 3 month follow-up

The system collects information on number of lessons completed, number of additional resources accessed, number of emails sent to and received from therapist. Participants' engagement is calculated by averaging the sum from all of the components listed above.

Collects engagement from time of consent to 3 month follow-up
Background Information
Lasso di tempo: Screening

Background information including demographic questions will be collected at screening for descriptive purposes. No scores are calculated.

Screening
Sleep history & treatment history
Lasso di tempo: Screening

Sleep and treatment history questions will be administered at screening for descriptive purposes. No scores are calculated based on these questions.

Screening

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Heather D Hadjistavropoulos, PhD, University of Regina

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

10 dicembre 2024

Completamento primario (Stimato)

1 dicembre 2026

Completamento dello studio (Stimato)

1 dicembre 2026

Date di iscrizione allo studio

Primo inviato

17 dicembre 2024

Primo inviato che soddisfa i criteri di controllo qualità

19 dicembre 2024

Primo Inserito (Effettivo)

20 dicembre 2024

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

4 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

2 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi